期刊文献+

替吉奥单药三线治疗老年晚期胰腺癌1例报道 被引量:5

暂未订购
导出
摘要 胰腺癌是全世界致死率最高的恶性肿瘤之一,5年生存率仅5%,中位生存期约6—8月。虽然外科手术是胰腺癌唯一的治愈手段,但多数患者因诊断时分期太晚而无法手术切除。即使可手术切除的患者,
作者 李元青 孙红
出处 《实用肿瘤杂志》 CAS 2014年第1期90-92,共3页 Journal of Practical Oncology
  • 相关文献

参考文献10

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2010 [ J]. Cancer J Clin,2010,60(5 ) :277 - 300.
  • 2Ciliberto D, Botta C, Correale P, et al. Role of gemcitabine-based combination therapy in the manage- ment of advanced pancreatic cancer: A meta-analysis of randomised trials [ J ]. Euro J Cancer,2013,49 (3) :593 - 603.
  • 3Yamagishi Y, Higuchi H, Izumiya M, et al. Gemcitabine as first-line chemotherapy in elderly patients with unresec- table pancreatic carcinoma [ J ]. J Gastroenterol, 2010,45 (11) :1146 - 1154.
  • 4Hwang IG, Jang JS, Oh SY, et al. A phase 11 trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer[ J]. Invest New Drags,2012, 30:2371 - 2376.
  • 5Fukutomi A, Uesaka K, Boku N, et al. JASPAC 01: Randomized phase IT[ trial of adjuvant chemotherapy with gemcitabine versus S-1 for patients with resected pancreatic cancer [ J ]. J Clin Oncol,2013,31 ( 15 ) : 4008.
  • 6吴莉莉,楼文晖,曾昭冲,曾蒙苏,李婷婷,姬巍.替吉奥同步放疗治疗局部晚期和复发性胰腺癌的Ⅱ期临床试验[J].上海医学,2011,34(5):367-370. 被引量:11
  • 7Kim HM,Bang S,Park JY,et al. Phase U trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer [ J ]. Cancer Chemother Pharmacol, 2009,63 (3) :535 - 541.
  • 8Nakai Y, Isayama H, Sasaki T, et al. Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan [ J ] Jpn J Clin Oncol, 2010,40 ( 8 ) : 774 - 780.
  • 9Akiko T,Akira F, Narikazu B, et al. S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure[J [. Jpn J Clin Oncol, 2010,40(6) : 567 - 572.
  • 10Sudo K, Yamaguchi T, Nakamura K, et al. Phase H study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer [ J ]. Cancer Chemother Pharmacol,2011,67(2) :249 - 254.

二级参考文献11

  • 1CRANE C H, VARADHACHARY G, PISTERS P W, et al. Future chemoradiation strategies in pancreatic cancer EJ~. Semin Oncol, 2007, 34: 335-346.
  • 2Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone[J]. J Natl Cancer Inst, 1988, 80: 751-755.
  • 3REGINE W F, WINTER K W, ABRAMS R, et al. RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma[J]. J Clin Oncol, 2006,24 : 4007.
  • 4MOERTEL C G, FRYTAK S, HAHN R G, et al. Therapy of locally unresectable pancreatic carcinoma., a randomized comparison of high dose (6000 rads ) radiation alone, moderate dose radiation (4000 fads q-5-fluorouracil), and high dose radiation q- 5-fluorouracil: The Gastrointestinal Tumor Study Group [J]. Cancer, 1981, 48: 1705-1710.
  • 5KIM H M, BANGS, PARKJ Y, et al. Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer [J]. Cancer Chemother Pharmacol, 2009, 63: 535-541.
  • 6AUPER1N A, LE PECHOUX C, ROLLAND E, et al. Meta analysis of concomitant versus sequential radiochemotherapy in locally advanced non small-cell lung cancer [J]. J Clin Oneol, 2010, 28:2181-2190.
  • 7FUJITA K, NAKAYAMA H, ICHIKAWA W, et al.Pharmacokinetics of 5 fluorouracil in elderly Japanese patients with cancer treated with S-l (a combination of tegafur and dihydropyrimidine dehydrogenase inhibitor 5-chloro 2, 4 dihydroxypyridine) [J]. Drug Metab Dispos, 2009, 37: 1375-1377.
  • 8SUDO K, YAMAGUCHI T, ISHIHARA T, et al. Phase 11 Study of Oral S-1 and Concurrent Radiotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer [J]. Int J Radiat Oncol Biol Phys, 2011, 80:119 125.
  • 9BJERREGAARD J K, MORTENSEN M B, JENSEN H A, et al. Long term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer [J]. Radiother Oned, 2009, 92:226- 230.
  • 10楼文晖.胰腺癌的非手术治疗进展[J].中国实用外科杂志,2008,28(2):90-92. 被引量:4

共引文献10

同被引文献47

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部